Biomarin Pharmaceutical Inc (BMRN)

Working capital turnover

		Sep 30, 2025	Jun 30, 2025	Mar 31, 2025	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020
Revenue (ttm)	US$ in thousands	3,094,001	3,063,608	2,950,227	2,853,915	2,752,809	2,588,398	2,471,644	2,419,226	2,310,557	2,234,572	2,173,095	2,096,039	2,008,311	1,911,709	1,879,604	1,846,275	1,848,588	1,916,630	1,844,422	1,860,435
Total current assets	US$ in thousands	3,854,540	3,805,330	3,467,900	3,232,430	3,056,590	3,259,630	2,985,010	2,956,090	2,955,310	2,950,120	2,842,100	2,751,460	2,682,700	2,517,600	2,394,020	2,274,380	2,311,570	2,357,840	2,288,770	2,342,220
Total current liabilities	US$ in thousands	798,438	684,247	628,213	606,988	715,658	1,067,340	1,087,900	1,177,020	1,163,220	597,231	598,231	588,884	521,020	464,727	490,418	539,822	514,898	443,344	430,035	492,548
Working capital turnover		1.01	0.98	1.04	1.09	1.18	1.18	1.30	1.36	1.29	0.95	0.97	0.97	0.93	0.93	0.99	1.06	1.03	1.00	0.99	1.01

September 30, 2025 calculation

Working capital turnover = Revenue (ttm) ÷ (Total current assets – Total current liabilities)
= $3,094,001K ÷ ($3,854,540K – $798,438K)
= 1.01

Sep 30, 2025

Company name

Symbol

Working capital turnover

Biomarin Pharmaceutical Inc

BMRN

1.01